Based on the CTLA-4 IHC expression and staining results, we inferred that most cases in our study showed moderate IHC expression (11-50% expression and 2+ staining intensity) in immune cells irrespective of the subtype of classical HL. The gene discussed is CTLA4; the disease is Hodgkins lymphoma.